The economic costs of heart attack and chest pain (Acute Coronary Syndrome)

Access Economics

Research output: Book/ReportCommissioned report

Abstract

Access Economics was commissioned by Eli Lilly to estimate the economic costs of Heart Attack and Chest Pain (Acute Coronary Syndrome-ACS) in Australia for 2009. In addition, an objective was to investigate current gaps in ACS treatment and clinical need, and highlight areas of treatment where further investment may result in significant benefits through a reduction in the burden of disease and improvements in efficiency and quality of care.
Original languageEnglish
PublisherAccess Economics Pty Limited
Commissioning bodyEli Lilly Australia Pty Ltd
Number of pages88
Publication statusPublished - Jun 2009
Externally publishedYes

Fingerprint Dive into the research topics of 'The economic costs of heart attack and chest pain (Acute Coronary Syndrome)'. Together they form a unique fingerprint.

Cite this